hers for semaglutide Weight Loss Care Women, Built to Last Hims & Hers abandons copycat
Description
If the framework identifies the pattern but not the source
With the launch of our oral semaglutide biosimilar, Obeda tablets, we are broadening our GLP1 portfolio to offer more choice and flexibility for patients
If it does the same job as the brand-name drug, its a copy
As the GLP-1 product market continues to expand, manufacturers must find ways to differentiate their inline and pipeline assets with new evidence and strong value story.
